Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains
M Shafaghi, Z Bahadori, H Madanchi, MM Ranjbar… - BMC …, 2023 - Springer
Abstract Background Streptococcus pneumoniae (Pneumococcus) has remained a leading
cause of fatal infections such as pneumonia, meningitis, and sepsis. Moreover, this …
cause of fatal infections such as pneumonia, meningitis, and sepsis. Moreover, this …
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface …
Background The pathogenicity of pneumococcus with high morbidity, mortality, and multi-
drug resistance patterns has been increasing. The limited coverage of the licensed …
drug resistance patterns has been increasing. The limited coverage of the licensed …
Immunoinformatics approach in designing epitope-based vaccine against meningitis-inducing bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and …
H Zahroh, A Ma'rup, USF Tambunan… - Drug target …, 2016 - journals.sagepub.com
Meningitis infection is one of the major threats during Hajj season in Mecca. Meningitis
vaccines are available, but their uses are limited in some countries due to religious reasons …
vaccines are available, but their uses are limited in some countries due to religious reasons …
Th17-mediated cross protection against pneumococcal carriage by vaccination with a variable antigen
K Kuipers, WSP Jong… - Infection and …, 2017 - Am Soc Microbiol
Serotype-specific protection against Streptococcus pneumoniae is an important limitation of
the current polysaccharide-based vaccines. To prevent serotype replacement, reduce …
the current polysaccharide-based vaccines. To prevent serotype replacement, reduce …
In Silico Study of Rotavirus VP7 Surface Accessible Conserved Regions for Antiviral Drug/Vaccine Design
Background Rotaviral diarrhoea kills about half a million children annually in developing
countries and accounts for one third of diarrhea related hospitalizations. Drugs and vaccines …
countries and accounts for one third of diarrhea related hospitalizations. Drugs and vaccines …
Cocaine vaccine development: evaluation of carrier and adjuvant combinations that activate multiple toll-like receptors
A Kimishima, CJ Wenthur, LM Eubanks… - Molecular …, 2016 - ACS Publications
Although cocaine abuse and addiction continue to cause serious health and societal
problems, an FDA-approved medication to treat cocaine addiction has yet to be developed …
problems, an FDA-approved medication to treat cocaine addiction has yet to be developed …
Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice
Streptococcus pneumoniae (pneumococcus) is a human pathogen that can cause otitis
media, pneumonia and, in severe cases, meningitis and bacteremia. The pneumococcus …
media, pneumonia and, in severe cases, meningitis and bacteremia. The pneumococcus …
A bioinformatics approach to designing a Zika virus vaccine
The Zika virus infections have reached epidemic proportions in the Latin American countries
causing severe birth defects and neurological disorders. While several organizations have …
causing severe birth defects and neurological disorders. While several organizations have …
Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
S Wu, T Yu, X Song, S Yi, L Hou, W Chen - Virology Journal, 2012 - Springer
Abstract Background Ebola viruses (EBOVs) cause severe hemorrhagic fever with a high
mortality rate. At present, there are no licensed vaccines or efficient therapies to combat …
mortality rate. At present, there are no licensed vaccines or efficient therapies to combat …
Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
Background Plasmodium falciparum apical membrane antigen-1 (AMA1) is a leading
malaria vaccine candidate antigen that is expressed by sporozoite, liver and blood stage …
malaria vaccine candidate antigen that is expressed by sporozoite, liver and blood stage …